Cryoprecipitate is a blood product derived from plasma, the liquid component of blood. It is rich in clotting factors, particularly fibrinogen, factor VIII, and von Willebrand factor. Cryoprecipitate is typically used to treat patients with bleeding disorders, such as hemophilia or those with low fibrinogen levels. To produce cryoprecipitate, fresh frozen plasma is thawed, and the precipitate that forms is collected. This product can be transfused to help promote blood clotting and control bleeding during surgeries or after trauma. It is an essential component in managing certain medical conditions related to coagulation.